Incretin and metabolic-axis peptides studied for GLP-1, GIP and glucagon receptor signalling in vitro.
10 products · Independently COA-verified · 24h Melbourne dispatch
GLP-1R / GIPR / GcgR triple agonist — metabolic pathway research
Dual GIP/GLP-1 receptor agonist — dual-incretin pathway research
OUT OF STOCK
GLP-1 receptor agonist — incretin signalling & cAMP assays
OUT OF STOCK
Long-acting amylin analog — AMY receptor signalling assays
OUT OF STOCK
GLP-1R / glucagon dual agonist — energy-metabolism models
OUT OF STOCK
GH fragment 176-191 — lipolytic-signalling models
OUT OF STOCK
Amylin + GLP-1 fixed-ratio combination — dual-pathway assays
OUT OF STOCK
5-Amino-1MQ — NNMT inhibition & cellular NAD⁺ research
OUT OF STOCK
GLP-1 / glucagon dual agonist — metabolic pathway research
OUT OF STOCK
For laboratory research use only. Not for human or veterinary use, and not for human consumption.
